title: Results of F-EVAR in octogenarians.
abstract: BACKGROUND
  To evaluate the clinical outcomes after fenestrated endovascular aortic aneurysm repair (F-EVAR) in octogenarians.
  
  
  METHODS
  Between 2002 and 2012, all data from patients treated with custom-made fenestrated endografts for elective juxtarenal or pararenal aortic aneurysms in 2 high-volume centers (Malmö, Sweden & Lille, France) were prospectively entered in a computer database. Demographics and perioperative and follow-up results of patients aged ≥80 years (group 1) and patients aged <80 (group 2) were compared.
  
  
  RESULTS
  A total of 288 patients (33 in group 1 and 255 in group 2) were treated with fenestrated endografts during the study period. Except for median age, tobacco use, and maximal transaortic diameter (P = 0.001), both groups were comparable. The number of fenestrations, procedure duration, contrast media volume, length of stay, and number of secondary interventions were comparable. The 30-day mortality rate was higher in the octogenarian group (9% vs. 1.6%, P = 0.041). Median follow-up was 25 months. Two-year survival rate according to Kaplan-Meier method was 77.8% in group 1 (95% confidence interval, 61.8-93.9) and 89.0% in group 2 (P = 0.121). Overall mortality during the follow-up period was significantly higher in octogenarians (P < 0.006).
  
  
  CONCLUSIONS
  F-EVAR in octogenarians is associated with a higher 30-day mortality rate but has similar midterm outcomes compared with younger patients and should be considered as an acceptable therapeutic option in patients with satisfactory life expectancy.
authors: Service de Chirurgie Vasculaire, Hôpital Cardiologique, CHRU Lille, Lille, France.
authors: Adrien
authors: A
authors: Hertault
authors: Service de Chirurgie Vasculaire, Hôpital Cardiologique, CHRU Lille, Lille, France.
authors: Jonathan
authors: J
authors: Sobocinski
authors: Vascular Center, Skåne University Hospital, Malmö, Sweden.
authors: Thorarinn
authors: T
authors: Kristmundsson
authors: Service de Chirurgie Vasculaire, Hôpital Cardiologique, CHRU Lille, Lille, France.
authors: Blandine
authors: B
authors: Maurel
authors: Vascular Center, Skåne University Hospital, Malmö, Sweden.
authors: Nuno V
authors: NV
authors: Dias
authors: Service de Chirurgie Vasculaire, Hôpital Cardiologique, CHRU Lille, Lille, France.
authors: Richard
authors: R
authors: Azzaoui
authors: Vascular Center, Skåne University Hospital, Malmö, Sweden.
authors: Björn
authors: B
authors: Sonesson
authors: Vascular Center, Skåne University Hospital, Malmö, Sweden.
authors: Timothy
authors: T
authors: Resch
authors: Service de Chirurgie Vasculaire, Hôpital Cardiologique, CHRU Lille, Lille, France. Electronic address: haulon@hotmail.com.
authors: Stéphan
authors: S
authors: Haulon
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D017544:Aortic Aneurysm, Abdominal / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation / Q000401:mortality; D016208:Databases, Factual; D057510:Endovascular Procedures / Q000009:adverse effects / Q000295:instrumentation / Q000401:mortality; D005260:Female; D005602:France; D061847:Hospitals, High-Volume; D006801:Humans; D053208:Kaplan-Meier Estimate; D008017:Life Expectancy; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011474:Prosthesis Design; D012189:Retrospective Studies; D012307:Risk Factors; D015607:Stents; D013548:Sweden; D013997:Time Factors; D016896:Treatment Outcome